SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

IDEAYA Biosciences, Inc. IDYA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

IDEAYA Biosciences, Inc. (IDYA) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ABOS, AMLX, ANAB, CERE, DAWN, FIXX 等.

IDYA 的市值为 $2.84B, 而同行平均市值为 $1.99B.

同行与相似公司 — IDYA

Acumen Pharmaceuticals, Inc.

$2.68 +6.77% $162.34M

Amylyx Pharmaceuticals, Inc.

$16.92 +2.73% $1.41B

AnaptysBio, Inc.

$70.22 +2.17% $2.02B

Cerevel Therapeutics Holdings, Inc.

$44.96 +0.74% $8.19B

Day One Biopharmaceuticals, Inc.

$21.46 -0.14% $2.22B

Homology Medicines, Inc.

$0.93 +0.77% $3.02M

Inozyme Pharma, Inc.

$4.00 +0.25% $258.25M

Keros Therapeutics, Inc.

$11.55 +3.59% $429.91M

MeiraGTx Holdings plc

$11.29 +17.24% $919.53M

MoonLake Immunotherapeutics

$18.78 +1.90% $1.35B

Protagonist Therapeutics, Inc.

$104.72 +7.33% $6.68B

Avidity Biosciences, Inc.

$14.02 +5.41% $217.52M

其他人也在看

Verona Pharma plc

Revolution Medicines, Inc.

Cerevel Therapeutics Holdings, Inc.

Protagonist Therapeutics, Inc.

Terns Pharmaceuticals, Inc.

SpringWorks Therapeutics, Inc.

Day One Biopharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言